Innovation in the biopharmaceutical industry is increasingly being driven by partnership deals. The variety and structure of these deals were discussed in early December 2014 in Lille, France at BioFIT, an event organised by the French life science group AFSSI. Industry executives and technology transfer officers argued that partnerships are becoming more common, and in some cases, more open-ended.
